Elsevier Congratulates its British Medical Association (BMA) Award Winning Medical Authors a... (roup PLC ( http://www.reedelsevi Medi...)

(Date:5/22/2013)... and NEW ORLEANS , May 22, ... field of regenerative medicine, presented new data generated in ... Group (a leading health economics consultancy) demonstrating the significant ... (DFU) and venous leg ulcers (VLU) place upon the ... this research, which reveal annual costs of up to ...

(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) , ... pleased to announce a sponsorship agreement with Erebus Motorsport ... distributor of DrugCheck® onsite testing devices, manufactured by EDI. ... Austin 400 May 17-19 in Austin, Texas. , Royal ... each car of the Erebus Motorsport team displaying the ...

(Date:5/22/2013)... -- Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics™, ... in vivo production of therapeutic proteins, announced today ... Moderna in early July as its first Chief Information ... in the design and implementation of information systems underlying ... clinical operations and commercial preparedness. John has also been ...

(Date:5/21/2013)... WA (PRWEB) May 21, 2013 Through ... trainings, and funds for lab equipment, 25 organizations will ... and importance of optics and photonics in daily life ... . , The organizations, located in 10 countries, are ... to be awarded by SPIE, the international society ...

Breaking Biology Technology:Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2 Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3 Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4 Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2 Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2 Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3 Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2 Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3

[0] Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers [0] Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team [0] Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer [0] Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants

... Partners B.V., a leading,GMP biopharmaceutical manufacturer, announced today ... ActoGeniX, drug substance AG011 for use in a,Phase ... ActoGeniX is focused on the development and commercialization ... can,be orally administered. The Company,s lead product AG011 ...

... JERSEY CITY, New Jersey, May 14, Rosetta Genomics (Nasdaq: ... financial results on May 21, 2008, before the,U.S. markets ... a,simultaneous webcast to discuss these results at 4:30 p.m. ... conference call, U.S. and Canadian participants may,dial +1-866-966-5335; international ...

... May 14 Access Pharmaceuticals, Inc.,(OTC Bulletin Board: ACCP) ... Rodman & Renshaw 5th Annual Global Healthcare Conference to ... Hotel in Monte Carlo, Monaco.,Jeffrey B. Davis, CEO of ... at 3:10 pm local time, 9:10 am Eastern time ...

Cached Biology Technology:SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 2 SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials 3 Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results 2 Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference 2

SynCo Bio Partners Completes Manufacture and Release of ActoGeniX' Lead Product for Phase II Clinical Trials Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference

(Date:5/21/2013)... A new analysis shows that the nation,s land ... enough algae to produce up to 25 billion gallons ... one-twelfth of the country,s yearly needs. , The findings ... that would be needed to grow significant amounts of ... were published in the May 7 issue of ...

(Date:5/21/2013)... Researchers at USC have found that a class of ... mice. , The drugs, known as "TSPO ligands," ... "We looked at the effects of TSPO ligand in ... stage, and in aged mice when pathology was quite ... Davis School of Gerontology. "TSPO ligand reduced measures of ...

(Date:5/21/2013)... Cancers of all types become most deadly when they ... has reached this stage, it becomes very difficult for ... can develop. Now, researchers at the University of Missouri ... target lymphoma tumor cells wherever they may be in ... in the MU College of Veterinary Medicine, says being ...

Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2 Going green: Nation equipped to grow serious amounts of pond scum for fuel 3 Going green: Nation equipped to grow serious amounts of pond scum for fuel 4 Drugs found to both prevent and treat Alzheimer's disease in mice 2 MU researchers develop radioactive nanoparticles that target cancer cells 2

[0] Going green: Nation equipped to grow serious amounts of pond scum for fuel [0] Drugs found to both prevent and treat Alzheimer's disease in mice [0] MU researchers develop radioactive nanoparticles that target cancer cells

... French . MONTREAL, March 1, 2011 ... rare genetic disease, researchers have discovered how three genes contribute ... understanding of many disorders such as foetal and childhood growth ... result of the Human Genome Project, we know the basic ...

... Cambridge, MASS- When your brain encounters sensory stimuli, such as ... a honking car, that input gets shuttled to the appropriate ... olfactory cortex, while sounds are processed in the auditory cortex. ... follows a predetermined, genetic blueprint. However, evidence is mounting that ...

... Canuel of the Virginia Institute of Marine Science ... Canada, and Mexico who have been awarded a ... As a Leopold Fellow, Canuel will participate in ... Capitol Hilldesigned to promote effective communication of science ...

Cached Biology News:Researchers looking at a rare disease make breakthrough that could benefit everyone 2 Researchers looking at a rare disease make breakthrough that could benefit everyone 3 MIT-- parts of brain can switch functions 2 MIT-- parts of brain can switch functions 3 MIT-- parts of brain can switch functions 4 VIMS professor selected as Leopold Fellow 2 VIMS professor selected as Leopold Fellow 3

Researchers looking at a rare disease make breakthrough that could benefit everyone MIT-- parts of brain can switch functions VIMS professor selected as Leopold Fellow

... EPS 301 Power Supply, 1. ... maximum.Constant voltage or constant current modes.Single-unit ... precision and reproducibility.Suitable for submarine, mini ... as well as semidry and mini ...

... Supply, 1. 1000 V, 400 mA, ... and constant power modes.Single-unit increments in ... reproducibility.Stores and recalls three protocols.Outstanding choice ... Multiphor II or GenePhor systems. ...

Mouse TrkC Affinity Purified Polyclonal Ab...

Immunogen: Full length M32 fusion protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...

Biology Products:

EPS 301 Power Supply from GE Healthcare, formerly Amersham Biosciences EPS 1001 Power Supply from GE Healthcare, formerly Amersham Biosciences Goat Anti-Mouse TrkC Polyclonal Antibody, Unconjugated from R&D Systems Rat Anti-HP1 gamma Monoclonal Antibody, Unconjugated, Clone MAC385 from ABR-Affinity BioReagents